細胞再生医療の世界市場レポート 2025年

細胞再生医療市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR14.4％で826億8,000万米ドルに成長します。予測期間の成長は、ホリカセクターからの再生医療製品に対する需要の高まり、移植用臓器の不足、研究開発活動の増加、遺伝子治療に対する需要の高まりに起因すると考えられます。予測期間における主な動向には、先進治療、臨床試験の拡大、組織工学と3Dバイオプリンティング、エクソソームベースの治療、個別化医療などがあります。

臓器移植の広範な採用が、当面の細胞再生医療市場の成長を牽引すると予測されます。臓器移植は、損傷したり欠損したりした臓器を置き換えるために、個人の体から臓器を取り出してレシピエントの体に移植する医療行為です。この医療行為は、寿命を延ばし、透析のような介入の必要性を減らすことができるため、大きな人気を博しています。細胞再生医療は、損傷した組織や臓器の修復と再生に焦点を当てることで、臓器移植を進歩させることが期待されています。例えば、2023年1月、米国を拠点に科学的・教育的イニシアチブを専門とする組織である臓器分与ネットワーク（United Network for Organ Sharing）が報告したところによると、米国では2022年に約42,887件の臓器移植手術が行われ、2021年と比較して3.7％増加しました。その結果、臓器移植の広範な受け入れが細胞再生医療市場の原動力となる見通しです。

慢性疾患の増加は、今後数年間の細胞再生医療市場の成長を牽引すると予想されます。慢性疾患とは、3ヶ月以上持続する病気で、時間の経過とともに悪化する傾向があります。細胞再生医療は、損傷した組織や臓器を修復し若返らせる革新的な方法を導入することで、慢性疾患の治療に有望な可能性を提供し、慢性疾患管理に革命をもたらす可能性のある研究や治療の新たな機会を創出します。例えば、2024年6月、政府機関であるオーストラリア保健福祉研究所は、慢性疾患による年齢標準化死亡率を、2020年には人口10万人当たり448人、2021年には10万人当たり459人、さらに2022年には10万人当たり490人と報告しました。その結果、慢性疾患の負担増が細胞再生医療市場の成長に拍車をかけています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、コロナ、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界細胞再生医療PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の細胞再生医療市場：成長率分析
• 世界の細胞再生医療市場の実績：規模と成長, 2019-2024
• 世界の細胞再生医療市場の予測：規模と成長, 2024-2029, 2034F
• 世界細胞再生医療総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の細胞再生医療市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 治療薬
• ツール
• 銀行
• サービス
• 世界の細胞再生医療市場治療カテゴリー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 皮膚科
• 筋骨格
• 免疫学と炎症
• 腫瘍学
• 心臓血管
• 眼科
• その他の治療カテゴリー
• 世界の細胞再生医療市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 商業産業
• 政府および学術調査機関
• 政府および学術調査機関
• 世界の細胞再生医療市場、治療薬のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 幹細胞療法
• 遺伝子治療
• 組織工学製品
• 世界の細胞再生医療市場ツールのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 細胞培養装置
• バイオリアクター
• イメージングシステム
• 世界の細胞再生医療市場、銀行の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 幹細胞バンク
• 組織バンク
• 臍帯血バンク
• 世界の細胞再生医療市場、サービスの種類別の細分化、実績と予測, 2019-2024, 2024-2029F, 2034F
• 細胞処理サービス
• 研究開発サービス
• 臨床試験サービス

第7章 地域別・国別分析

• 世界の細胞再生医療市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の細胞再生医療市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 細胞再生医療市場：競合情勢
• 細胞再生医療市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • F.Hoffman-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Novartis AG
• Bristol-Myers Squibb Company
• Medtronic Plc
• Eli Lilly and Company
• Boehringer Ingelheim International GmbH
• Amgen Inc.
• ViaCord LLC
• Stryker Corporation
• Zimmer Biomet Holdings Inc.
• Cook Biotech Inc.
• Integra LifeSciences Holdings Corporation
• NuVasive Inc.
• Organogenesis Holdings Inc.
• AMAG Pharmaceuticals Inc.
• Takara Bio Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 細胞再生医療市場2029：新たな機会を提供する国
• 細胞再生医療市場2029：新たな機会を提供するセグメント
• 細胞再生医療市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Cell regeneration medicine is a field within medical science and technology that centers on harnessing the inherent capacity of cells to mend, replace, and regenerate damaged or ailing tissues and organs within the human body. This discipline employs diverse cellular therapies, tissue engineering techniques, and regenerative medicine strategies to facilitate healing and reinstate functionality to compromised areas.

The key components of cell regeneration medicine encompass therapeutics, tools, banks, and services. Therapeutics pertain to the medical treatment and care of patients with the objective of both preventing and managing diseases, alleviating pain or injury, and addressing conditions like injuries and diseases through methods such as immunomodulation therapy and tissue engineering. These therapeutics are classified into specific categories, including dermatology, musculoskeletal, immunology and inflammation, oncology, cardiovascular, ophthalmology, and others. They find application across various sectors, serving end-users like hospitals and clinics, commercial industries, government institutions, and academic research institutes.

The cell regeneration medicine research report is one of a series of new reports from The Business Research Company that provides cell regeneration medicine market statistics, including the cell regeneration medicine global market size, regional shares, competitors with a cell regeneration medicine market share, detailed cell regeneration medicine market segments, market trends and opportunities and any further data you may need to thrive in the cell regeneration medicine industry. This cell regeneration medicine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The cell regeneration medicine market size has grown rapidly in recent years. It will grow from $41.83 billion in 2024 to $48.25 billion in 2025 at a compound annual growth rate (CAGR) of 15.4%. The growth in the historic period can be attributed to aging population, prevalence of chronic diseases, growing government and corporate funding, growing demand for functional regenerative medicine products.

The cell regeneration medicine market size is expected to see rapid growth in the next few years. It will grow to $82.68 billion in 2029 at a compound annual growth rate (CAGR) of 14.4%. The growth in the forecast period can be attributed to rising demand for regenerative medicine products from the horeca sector, shortage of organs for transplantation, increasing r&d activities, growing demand for gene therapies. Major trends in the forecast period include advanced therapies, clinical trial expansion, tissue engineering and 3d bioprinting, exosome-based therapies, personalized medicine.

The extensive adoption of organ transplantation is anticipated to drive the growth of the cell regeneration medicine market in the foreseeable future. Organ transplantation is a medical procedure involving the removal of an organ from one individual's body and its placement into the body of a recipient to replace a damaged or missing organ. This medical practice has gained significant popularity due to its ability to extend lives and reduce the need for interventions like dialysis. Cell regenerative medicine holds the promise of advancing organ transplantation by focusing on the repair and regeneration of damaged tissues or organs. For instance, in January 2023, as reported by the United Network for Organ Sharing, a US-based organization specializing in scientific and educational initiatives, the United States witnessed approximately 42,887 organ transplant procedures in 2022, marking a 3.7% increase compared to 2021. Consequently, the widespread acceptance of organ transplants is poised to be a driving force behind the cell regeneration medicine market.

The increasing prevalence of chronic diseases is expected to drive the growth of the cell regeneration medicine market in the coming years. Chronic diseases are illnesses that persist for three months or longer and tend to worsen over time. Cell regeneration medicine offers promising potential for treating chronic diseases by introducing innovative methods to repair and rejuvenate damaged tissues and organs, creating new opportunities for research and therapies that could revolutionize chronic disease management. For example, in June 2024, the Australian Institute of Health and Welfare, a government agency, reported an age-standardized death rate due to chronic conditions of 448 per 100,000 population in 2020, which rose to 459 per 100,000 in 2021, and further to 490 per 100,000 in 2022. Consequently, the increasing burden of chronic diseases is fueling the growth of the cell regeneration medicine market.

Leading companies in the cell regeneration medicine market are focusing on the development of medical-grade bioink to enhance their competitive position. Medical-grade bioink is a specialized ink designed for bioprinting that adheres to strict regulatory standards for safety and biocompatibility, making it ideal for use in tissue engineering, regenerative medicine, and creating biological structures for medical applications. For example, in October 2023, CELLINK, a Sweden-based company known for its innovations in cell regeneration medicine, introduced CELLINK Vivoink. This is the first medical-grade bioink created specifically for clinical applications in regenerative medicine and tissue engineering, optimized for exceptional printability, mechanical stability, and cell viability.

In April 2022, Metcela Inc., a Japanese biotechnology firm with expertise in heart disease treatment, completed the acquisition of Japan Regenerative Medicine Co. Ltd. (JRM) for an undisclosed sum. This acquisition provides Metcela with the opportunity to diversify and enhance its product development portfolio through the addition of JRM-001. This innovative product utilizes cardiac stem cells to facilitate the restoration of cardiac tissues, particularly for the treatment of heart diseases. Japan Regenerative Medicine Co. Ltd. (JRM) is a Japanese biotechnology company primarily focused on the development of regenerative medicine solutions for heart diseases.

Major companies operating in the cell regeneration medicine market are Pfizer Inc., Johnson & Johnson, F.Hoffman-La Roche Ltd., AbbVie Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, Medtronic PLC, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Amgen Inc., ViaCord LLC, Stryker Corporation, Zimmer Biomet Holdings Inc., Cook Biotech Inc., Integra LifeSciences Holdings Corporation, NuVasive Inc., Organogenesis Holdings Inc., AMAG Pharmaceuticals Inc., Takara Bio Inc., MiMedx Group Inc., Vericel Corporation, Mesoblast Limited, Osiris Therapeutics Inc., Guanhao Biotech Co. Ltd., CordLife Group Limited, FUJIFILM Cellular Dynamics Inc., Cesca Therapeutics Inc., U.S. Stem Cell Inc., Cytori Therapeutics Inc.

North America was the largest region in the cell regeneration medicine market in 2024. The regions covered in cell regeneration medicine report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the cell regeneration medicine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cell regeneration medicine market includes revenues earned by entities by providing stem cell treatments, cartilage regeneration, platelet-rich plasma and tissue engineering. The market value includes the value of related goods sold by the service provider or included within the service offering. The cell regeneration medicine market also includes of sales of various types of cell regeneration medicines, such as stem cells and progenitor cells. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cell Regeneration Medicine Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cell regeneration medicine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cell regeneration medicine ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cell regeneration medicine market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Therapeutics; Tools; Banks; Services
• 2) By Therapeutic Category: Dermatology; Musculoskeletal; Immunology And Inflammation; Oncology; Cardiovascular; Ophthalmology; Other Therapeutic Categories
• 3) By End-User: Hospitals And Clinics; Commercial Industries; Government And Academic Research Institutes
• Subsegments:
• 1) By Therapeutics: Stem Cell Therapies; Gene Therapies; Tissue Engineering Products
• 2) By Tools: Cell Culture Equipment; Bioreactors; Imaging Systems
• 3) By Banks: Stem Cell Banks; Tissue Banks; Cord Blood Banks
• 4) By Services: Cell Processing Services; Research And Development Services; Clinical Trial Services
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson; F.Hoffman-La Roche Ltd.; AbbVie Inc.; Bayer AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cell Regeneration Medicine Market Characteristics

3. Cell Regeneration Medicine Market Trends And Strategies

4. Cell Regeneration Medicine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Cell Regeneration Medicine Growth Analysis And Strategic Analysis Framework

• 5.1. Global Cell Regeneration Medicine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Cell Regeneration Medicine Market Growth Rate Analysis
• 5.4. Global Cell Regeneration Medicine Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Cell Regeneration Medicine Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Cell Regeneration Medicine Total Addressable Market (TAM)

6. Cell Regeneration Medicine Market Segmentation

• 6.1. Global Cell Regeneration Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Therapeutics
• Tools
• Banks
• Services
• 6.2. Global Cell Regeneration Medicine Market, Segmentation By Therapeutic Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Dermatology
• Musculoskeletal
• Immunology And Inflammation
• Oncology
• Cardiovascular
• Ophthalmology
• Other Therapeutic Categories
• 6.3. Global Cell Regeneration Medicine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Commercial Industries
• Government And Academic Research Institutes
• Government And Academic Research Institutes
• 6.4. Global Cell Regeneration Medicine Market, Sub-Segmentation Of Therapeutics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Stem Cell Therapies
• Gene Therapies
• Tissue Engineering Products
• 6.5. Global Cell Regeneration Medicine Market, Sub-Segmentation Of Tools, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cell Culture Equipment
• Bioreactors
• Imaging Systems
• 6.6. Global Cell Regeneration Medicine Market, Sub-Segmentation Of Banks, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Stem Cell Banks
• Tissue Banks
• Cord Blood Banks
• 6.7. Global Cell Regeneration Medicine Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cell Processing Services
• Research And Development Services
• Clinical Trial Services

7. Cell Regeneration Medicine Market Regional And Country Analysis

• 7.1. Global Cell Regeneration Medicine Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Cell Regeneration Medicine Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cell Regeneration Medicine Market

• 8.1. Asia-Pacific Cell Regeneration Medicine Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Cell Regeneration Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Cell Regeneration Medicine Market, Segmentation By Therapeutic Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Cell Regeneration Medicine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cell Regeneration Medicine Market

• 9.1. China Cell Regeneration Medicine Market Overview
• 9.2. China Cell Regeneration Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Cell Regeneration Medicine Market, Segmentation By Therapeutic Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Cell Regeneration Medicine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cell Regeneration Medicine Market

• 10.1. India Cell Regeneration Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Cell Regeneration Medicine Market, Segmentation By Therapeutic Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Cell Regeneration Medicine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cell Regeneration Medicine Market

• 11.1. Japan Cell Regeneration Medicine Market Overview
• 11.2. Japan Cell Regeneration Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Cell Regeneration Medicine Market, Segmentation By Therapeutic Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Cell Regeneration Medicine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cell Regeneration Medicine Market

• 12.1. Australia Cell Regeneration Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Cell Regeneration Medicine Market, Segmentation By Therapeutic Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Cell Regeneration Medicine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cell Regeneration Medicine Market

• 13.1. Indonesia Cell Regeneration Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Cell Regeneration Medicine Market, Segmentation By Therapeutic Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Cell Regeneration Medicine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cell Regeneration Medicine Market

• 14.1. South Korea Cell Regeneration Medicine Market Overview
• 14.2. South Korea Cell Regeneration Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Cell Regeneration Medicine Market, Segmentation By Therapeutic Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Cell Regeneration Medicine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cell Regeneration Medicine Market

• 15.1. Western Europe Cell Regeneration Medicine Market Overview
• 15.2. Western Europe Cell Regeneration Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Cell Regeneration Medicine Market, Segmentation By Therapeutic Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Cell Regeneration Medicine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cell Regeneration Medicine Market

• 16.1. UK Cell Regeneration Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Cell Regeneration Medicine Market, Segmentation By Therapeutic Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Cell Regeneration Medicine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cell Regeneration Medicine Market

• 17.1. Germany Cell Regeneration Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Cell Regeneration Medicine Market, Segmentation By Therapeutic Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Cell Regeneration Medicine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cell Regeneration Medicine Market

• 18.1. France Cell Regeneration Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Cell Regeneration Medicine Market, Segmentation By Therapeutic Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Cell Regeneration Medicine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cell Regeneration Medicine Market

• 19.1. Italy Cell Regeneration Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Cell Regeneration Medicine Market, Segmentation By Therapeutic Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Cell Regeneration Medicine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cell Regeneration Medicine Market

• 20.1. Spain Cell Regeneration Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Cell Regeneration Medicine Market, Segmentation By Therapeutic Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Cell Regeneration Medicine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cell Regeneration Medicine Market

• 21.1. Eastern Europe Cell Regeneration Medicine Market Overview
• 21.2. Eastern Europe Cell Regeneration Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Cell Regeneration Medicine Market, Segmentation By Therapeutic Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Cell Regeneration Medicine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cell Regeneration Medicine Market

• 22.1. Russia Cell Regeneration Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Cell Regeneration Medicine Market, Segmentation By Therapeutic Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Cell Regeneration Medicine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cell Regeneration Medicine Market

• 23.1. North America Cell Regeneration Medicine Market Overview
• 23.2. North America Cell Regeneration Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Cell Regeneration Medicine Market, Segmentation By Therapeutic Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Cell Regeneration Medicine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cell Regeneration Medicine Market

• 24.1. USA Cell Regeneration Medicine Market Overview
• 24.2. USA Cell Regeneration Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Cell Regeneration Medicine Market, Segmentation By Therapeutic Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Cell Regeneration Medicine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cell Regeneration Medicine Market

• 25.1. Canada Cell Regeneration Medicine Market Overview
• 25.2. Canada Cell Regeneration Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Cell Regeneration Medicine Market, Segmentation By Therapeutic Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Cell Regeneration Medicine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cell Regeneration Medicine Market

• 26.1. South America Cell Regeneration Medicine Market Overview
• 26.2. South America Cell Regeneration Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Cell Regeneration Medicine Market, Segmentation By Therapeutic Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Cell Regeneration Medicine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cell Regeneration Medicine Market

• 27.1. Brazil Cell Regeneration Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Cell Regeneration Medicine Market, Segmentation By Therapeutic Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Cell Regeneration Medicine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cell Regeneration Medicine Market

• 28.1. Middle East Cell Regeneration Medicine Market Overview
• 28.2. Middle East Cell Regeneration Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Cell Regeneration Medicine Market, Segmentation By Therapeutic Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Cell Regeneration Medicine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cell Regeneration Medicine Market

• 29.1. Africa Cell Regeneration Medicine Market Overview
• 29.2. Africa Cell Regeneration Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Cell Regeneration Medicine Market, Segmentation By Therapeutic Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Cell Regeneration Medicine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cell Regeneration Medicine Market Competitive Landscape And Company Profiles

• 30.1. Cell Regeneration Medicine Market Competitive Landscape
• 30.2. Cell Regeneration Medicine Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. F.Hoffman-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

31. Cell Regeneration Medicine Market Other Major And Innovative Companies

• 31.1. Novartis AG
• 31.2. Bristol-Myers Squibb Company
• 31.3. Medtronic Plc
• 31.4. Eli Lilly and Company
• 31.5. Boehringer Ingelheim International GmbH
• 31.6. Amgen Inc.
• 31.7. ViaCord LLC
• 31.8. Stryker Corporation
• 31.9. Zimmer Biomet Holdings Inc.
• 31.10. Cook Biotech Inc.
• 31.11. Integra LifeSciences Holdings Corporation
• 31.12. NuVasive Inc.
• 31.13. Organogenesis Holdings Inc.
• 31.14. AMAG Pharmaceuticals Inc.
• 31.15. Takara Bio Inc.

32. Global Cell Regeneration Medicine Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cell Regeneration Medicine Market

34. Recent Developments In The Cell Regeneration Medicine Market

35. Cell Regeneration Medicine Market High Potential Countries, Segments and Strategies

• 35.1 Cell Regeneration Medicine Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Cell Regeneration Medicine Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Cell Regeneration Medicine Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer